Physiologically assessed collateral flow and intracoronary growth factor concentrations in patients with 1- to 3-vessel coronary artery disease

Circulation. 2001 Jan 30;103(4):E22. doi: 10.1161/01.cir.103.4.e22.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anticoagulants / administration & dosage
  • Collateral Circulation*
  • Coronary Disease / blood
  • Coronary Disease / physiopathology*
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism*
  • Coronary Vessels / physiopathology
  • Endothelial Growth Factors / blood
  • Fibroblast Growth Factor 2 / blood
  • Growth Substances / blood*
  • Heparin / administration & dosage
  • Humans

Substances

  • Anticoagulants
  • Endothelial Growth Factors
  • Growth Substances
  • Fibroblast Growth Factor 2
  • Heparin